HC strong on proposed AZ delisting

Minority stakeholders accuse AZ of allocating shares to selected investors in the offer for sale in 2013


According to Mint, the Bombay high court has stayed the proposed delisting of AstraZeneca Pharma India Ltd after two minority shareholders moved the court against the plan following an investigation by the market regulator that found alleged evidence of "collaboration" between the company's Swedish parent AstraZeneca Pharmaceuticals AB and the Elliott group of investors in its offer for sale (OFS) last year.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email